Atria Wealth Solutions, Inc. Trinity Biotech PLC Transaction History

Atria Wealth Solutions, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$0.87 - $1.18 $29,841 - $40,474	34,300 New	34,300 $32,000
Q4 2022 Aug 30, 2023	BUY	$0.98 - $6.15 $33,614 - $210,945	34,300 New	34,300 $33,000
Q4 2022 Feb 13, 2023	BUY	$0.98 - $6.15 $9,408 - $59,040	9,600 Added 38.87%	34,300 $33,000
Q2 2022 Aug 15, 2022	SELL	$0.96 - $1.44 $768 - $1,152	-800 Reduced 3.14%	24,700 $30,000
Q1 2022 May 16, 2022	BUY	$0.92 - $1.44 $23,460 - $36,720	25,500 New	25,500 $27,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $42.7M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.